- Treeline to go public via reverse merger with Standard BioToolsTreeline Biosciences has shared plans to debut on public markets through a reverse merger with Standard BioTools in a move that should give the company a cash runway through 2029. TheEndpoints · 1mo ago↗ source
- J&J makes $1B move for Firefly Bio, Carolyn Bertozzi's twist on ADCs in KRAS fieldJohnson & Johnson is making another early-stage oncology deal, dishing out $1 billion in cash to acquire Firefly Bio, a preclinical startup working on degrader antibody conjugates. J&J no…Endpoints · 1mo ago↗ source
- GSK inks multi-target pact with Engitix; Sangamo considers strategic optionsPlus news about Pfizer's latest label expansion. 🤝 GSK inks multi-target liver pact with Engitix: London-based Engitix will use disease models based on its extracellular matrix technology to ide…